Literature DB >> 33439992

Mitochondria-related core genes and TF-miRNA-hub mrDEGs network in breast cancer.

Li-Rong Yan1, Ang Wang1, Zhi Lv1, Yuan Yuan1, Qian Xu1.   

Abstract

BACKGROUND: Mitochondria-nuclear cross-talk and mitochondrial retrograde regulation are involved in the genesis and development of breast cancer (BC). Therefore, mitochondria can be regarded as a promising target for BC therapeutic strategies. The present study aimed to construct regulatory network and seek the potential biomarkers of BC diagnosis and prognosis as well as the molecular therapeutic targets from the perspective of mitochondrial dysfunction.
METHODS: The microarray data of mitochondria-related encoding genes in BC cell lines were downloaded from GEO including GSE128610 and GSE72319. GSE128610 was treated as test set and validation sets consisted of GSE72319 and TCGA tissue samples, intending to identify mitochondria-related differentially expressed genes (mrDEGs). We performed enrichment analysis, PPI network, hub mrDEGs and overall survival analysis and constructed transcription factor (TF)-miRNA-hub mrDEGs network.
RESULTS: A total of 23 up-regulated and 71 down-regulated mrDEGs were identified and validated in BC cell lines and tissues. Enrichment analyses indicated that mrDEGs were associated with several cancer-related biological processes. Moreover, 9 hub mrDEGs were identified and validated in BC cell lines and tissues. Finally, 5 hub coregulated mrDEGs, 21 miRNAs and 117 TFs were used to construct TF-miRNA-hub mrDEGs network. MYC associated zinc finger protein (MAZ), heparin binding growth factor (HDGF) and Sp2 transcription factor (SP2) regulated 3 hub mrDEGs. Hsa-mir-21-5p, hsa-mir-1-3p, hsa-mir-218-5p, hsa-mir-26a-5p and hsa-mir-335-5p regulated 2 hub mrDEGs. Overall survival analysis suggested that the up-regulation of fibronectin 1 (FN1), as well as the down-regulation of discoidin domain receptor tyrosine kinase 2 (DDR2) correlated with unfavorable prognosis in BC.
CONCLUSION: TF-miRNA-hub mrDEGs had instruction significance for the exploration of BC etiology. The hub mrDEGs such as FN1 and DDR2 were likely to regulate mitochondrial function and be novel biomarkers for BC diagnosis and prognosis as well as the therapeutic targets.
© 2021 The Author(s).

Entities:  

Keywords:  Breast cancer; biomarker; miRNA; mitochondria; prognosis; transcription factor

Mesh:

Substances:

Year:  2021        PMID: 33439992      PMCID: PMC7843495          DOI: 10.1042/BSR20203481

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  6 in total

1.  A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.

Authors:  Hongli Gao; Fei Xing
Journal:  BMC Med Inform Decis Mak       Date:  2022-10-22       Impact factor: 3.298

2.  Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies.

Authors:  Md Shahin Alam; Adiba Sultana; Md Selim Reza; Md Amanullah; Syed Rashel Kabir; Md Nurul Haque Mollah
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

3.  KLF9 regulates miR-338-3p/NRCAM axis to block the progression of osteosarcoma cells.

Authors:  Yunlu Liu; Kuijing Han; Yulin Cao; Yuxiang Hu; Zengwu Shao; Wei Tong; Yanjiu Han; Yong Liu
Journal:  J Cancer       Date:  2022-03-28       Impact factor: 4.207

4.  Prognostic microRNAs associated with phosphoserine aminotransferase 1 in gastric cancer as markers of bone metastasis.

Authors:  Jingwei Ma; Meng Zhu; Xiaofeng Ye; Bo Wu; Tao Wang; Muyuan Ma; Tao Li; Ning Zhang
Journal:  Front Genet       Date:  2022-08-19       Impact factor: 4.772

5.  Transcriptome Analysis Reveals Hub Genes Regulating Autophagy in Patients With Severe COVID-19.

Authors:  Jinfeng Huang; Yimeng Wang; Yawen Zha; Xin Zeng; Wenxing Li; Meijuan Zhou
Journal:  Front Genet       Date:  2022-07-18       Impact factor: 4.772

Review 6.  MicroRNA-1: Diverse role of a small player in multiple cancers.

Authors:  Parvez Khan; Nivetha Sarah Ebenezer; Jawed Akhtar Siddiqui; Shailendra Kumar Maurya; Imayavaramban Lakshmanan; Ravi Salgia; Surinder Kumar Batra; Mohd Wasim Nasser
Journal:  Semin Cell Dev Biol       Date:  2021-05-24       Impact factor: 7.727

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.